Risk factors for amiodarone-induced liver injury: A retrospective analysis of medical records
Int. Journal of Clinical Pharmacology and Therapeutics · 2023
DOI: 10.5414/cp204428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2023. Verfasst von Hinoo Nagai und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Amiodarone, Chemical and Drug Induced Liver Injury, Chronic, Chemical and Drug Induced Liver Injury.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Nagai, H., Amemiya, T., & Suzuki, H. (2023). Risk factors for amiodarone-induced liver injury: A retrospective analysis of medical records. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204428
Vancouver
Nagai H, Amemiya T, Suzuki H. Risk factors for amiodarone-induced liver injury: A retrospective analysis of medical records. Int. Journal of Clinical Pharmacology and Therapeutics. 2023. doi:10.5414/cp204428
BibTeX
@article{Nagai2023,
author = {Nagai, Hinoo and Amemiya, Takahiro and Suzuki, Hiroshi},
title = {Risk factors for amiodarone-induced liver injury: A retrospective analysis of medical records},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2023},
doi = {10.5414/cp204428}
}
EUVIMED